Home  - Health_Conditions - Bergers Disease

Books Baby Camera Phones Computers Games DVD Electronics Kitchen Magazines Music Garden Software Tools Toys Video Apparel & Accessories Jewelry & Watches Musical Instruments Health & Personal Care Beauty Sports & Outdoors Office Products

e99.com Bookstore

Images

Newsgroups

41-60 of 89    Back | 1  | 2  | 3  | 4  | 5  | Next 20

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Bergers Disease:     more books (100)

An epitome of the diagnosis of nervous diseases including bromide therapy by Henry Irving Berger, 1914 Diagnosis of Diseases of the Liver and Gall-bladder 1927 By Berger The Blood and It's Diseases By Henry Irving Berger, M.d. Diagnosis of cardio-vascular diseases: Cardiology by Henry Irving Berger, 1931 Diagnosis of genito-urinary diseases and syphilis by Henry Irving Berger, 1933 Diagnosis of genito-urinary diseases and urinalysis by Henry Irving Berger, 1937 The blood and its diseases by Henry Irving Berger, 1915 Andrews' Diseases of the Skin: Clinical Dermatology - Expert Consult - Online and Print by William D. James MD, Timothy Berger MD, et all 2011-01-31 Diagnosis Of Cardiovascular Diseases (1912) by Henry Irving Berger, 2010-09-10 Brain Acetylcholine and Neuropsychiatric Disease by Philip A. Berger, 1979-05-01 Of natural causes: The disease and death of just about everybody by Stephen A Berger, 1982 Pigs as source for toxigenic Corynebacterium ulcerans.(LETTERS)(Report): An article from: Emerging Infectious Diseases by Regina Schuhegger, Christoph Schoerner, et all 2009-08-01 Brain Fitness: Anti-Aging to Fight Alzheimer's Disease, Supercharge Your Memory, by ROBERT MD GOLDMAN~LISA BERGER~RONALD KLATZ, 1999 Diagnosis of cardiovascular diseases: Cardiology by Henry Irving Berger, 1946

lists with details

41. ¤H¦W¯e¯f A-D
    bergers' disease, IgA nephropathy (nephritis), 2040y/o, ,URI?diffuse mesangial cell.  
    http://home.kimo.com.tw/kcchen63/shortAD.htm
    
    Extractions: B Bartter's syndrome AR, BP normal, J-G cell¼W¥Í, Renin aldosteron PGE2¡ô( K¡õ, BP-, HCO3¡ô) Behcet's syndrome Oral, genital ulcer + iritis + cutaneous lesion Benedikt's syndrome Bergers' disease IgA nephropathy (nephritis), 20-40y/o, ¤ÏÂЩʦ姿³Ì±`¨£­ì¦]¡A±`©óURI¤§«á¡C¥i¨£diffuse mesangial cell¼W¥Í Bowen's disease ¥~³±³¡ªºCIS Brunners disease Bruton's disease X-linked, ¯Ê¤ÖB cell Budd-chiari syndrome ¨xÀR¯ß¬C¶ë Buerger's disease ¦å®ê©ÊÀR¯ßª¢¡A»P©â·Ï¦³ö¡Bµh

42. UCSF Today News
    drug, Avastin, did not increase survival or slow disease progression in clinical studiesand laboratory research, and Gabriele bergers, assistant professor of  
    http://pub.ucsf.edu/today/cache/news/200212182.html
    
    Extractions: Webview: ... News Releases Scientist Judah Folkman. Photo by Chris Anderson. First Appeared Thursday, 19 December '02 ‘War on Cancer’ Talks Draw Overflow Crowd There is no reason to write-off “anti-angiogenesis” drugs for cancer. That was one of the messages by leading cancer scientists who recently discussed “The War on Cancer: Where are We?” The December 7 event, dubbed a “minisymposium” by organizers, drew an overflow crowd to the HSW 300 auditorium on Parnassus. E-mail story The symposium featured talks by several UCSF researchers, an industry scientist, and Judah Folkman, the Julia Dyckman Andrus Professor of Pediatric Surgery at Children’s Hospital Boston and Harvard Medical School, whose laboratory studies of new blood vessel growth, a phenomenon known as angiogenesis, have attracted an unusual amount of media attention in recent years. Studies published by Folkman and colleagues in 1998 led to much hype: a front-page New York Times article quoted DNA double helix co-discoverer James D. Watson, saying that Folkman was going to cure cancer. Reports of Folkman’s mouse studies described how tumors disappeared when treated with endostatin or angiostatin, natural “anti-angiogenesis” proteins first identified in the Folkman laboratory. Solid tumors need their own blood supply to grow larger than the smallest pinhead, and this knowledge, along with Folkman’s laboratory findings, have been driving forces behind pharmaceutical industry efforts to develop anti-angiogenesis drugs that target new blood vessel growth in cancer.

43. Gabriele Bergers PhD
    designed preclinical trials at three distinct stages of disease progression aimedat Dr bergers’ laboratory has expanded studies to elucidate crucial factors  
    http://www.som.ucsf.edu/neuros/faculty/bios/BergersG.htm
    
    Extractions: Brain Tumor Research Center Dr Bergers studies the functional importance of angiogenesis in tumor development and progression. She has utilized a transgenic mouse model of pancreatic islet cell carcinogenesis to elucidate mechanisms and impact of angiogenesis during tumor formation. She identified that the angiogenic factor VEGF is critical for the angiogenic switch and regulated posttranscriptionally, via proteolytic release from the extracellular matrix by the metalloproteinase MMP-9 that is expressed by inflammatory cells. This work was published in Nature Cell Biology in 2000. She furthermore translated the studies into experimental therapeutic approaches and designed preclinical trials at three distinct stages of disease progression aimed at preventing the angiogenic switch in premalignant lesions, intervening in the rapid expansion of small tumors, or inducing the regression of large end-stage cancers. She was the first to publish that angiogenesis inhibitors have different efficacies depending on the stage of carcinogenesis being targeted (

44. CANCER CHEMOTHERAPY - DISEASE THERAPIES PROTOCOL
    Hanahan, D., bergers, G., Bergsland, E. Less is more, regularly metronomic dosingof in patients undergoing chemo and/or radiotherapy for neoplastic disease.  
    http://www.lef.org/protocols/prtcl-024refs.html
    
    Extractions: Research Health Concerns Funded Research Track Record Innovative Doctors ... Scientific Advisory Free Product Directory Click for a FREE copy of our Product Directory LEF Membership What is LEF? Benefits Become a Member Renewals ... Become a Subscriber Our call center has now expanded its hours Monday thru Friday: 8:30am to 12:00am EST 5:30am to 9:00pm PST Saturday hours are: 9:00am to 8:00pm EST 6:00am to 5:00pm PST Sunday hours are: 11:00am to 7:00pm EST 8:00am to 4:00pm PST If you'd like to order by phone or speak to a live person for help, just call toll free: Customer Service Info Privacy Policy We subscribe to the HONcode principles. Verify here CANCER CHEMOTHERAPY Agarwal, B., Rao, C.V., Bhendwal, S., Ramey, W.R., Shirin, H., Reddy, B.S., Holt, P.R. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology 1999 Oct; 117(4): 838-47. Agha, A.M., El-Fattah, A.A., Al-Zuhair, H.H., Al-Rikabi, A.C. Chemopreventive effect of Ginkgo biloba extract against benzo(a)pyrene-induced forestomach carcinogenesis in mice: amelioration of doxorubicin cardiotoxicity. J. Exp. Clin. Cancer Res. 2001 Mar; 20(1): 39-50.

45. EMedicine - Hyperkeratosis Lenticularis Perstans (Flegel Disease) : Article By D
    Ralfs IG, Ryan TJ, Dawber RP Hyperkeratosis lenticularis perstans (Flegel's disease). vande Staak WJ, bergers AM, Bongaarts P Hyperkeratosis lenticularis  
    http://www.emedicine.com/derm/topic183.htm
    
    Extractions: (advertisement) Home Specialties CME PDA ... Patient Education Articles Images CME Patient Education Advanced Search Link to this site Back to: eMedicine Specialties Dermatology Papulosquamous Diseases Last Updated: November 30, 2001 Rate this Article Email to a Colleague AUTHOR INFORMATION Section 1 of 11 Author Information Introduction Clinical Differentials ... Bibliography Author: Daniel Roling, MD , Staff Physician, Department of Dermatology, University of Pennsylvania Hospital Coauthor(s): Jacqueline M Junkins-Hopkins, MD , Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine Daniel Roling, MD, is a member of the following medical societies: Pennsylvania Medical Society Editor(s): Julia R Nunley, MD , Program Director, Associate Professor, Department of Dermatology, Medical College of Virginia; Richard Vinson, MD , Chief, Department of Dermatology, William Beaumont Medical Center; Rosalie Elenitsas, MD , Director of Dermatopathology, Associate Professor, Department of Dermatology, University of Pennsylvania;

46. Dr. Bergers Ocean Of Hope
    Active Server Page, ASP Shopping Cart with Source Code. Active Server Page Components and Applications, CartEasy  
    http://www.oceanofhope.com/vertlinks.asp?page=Environment&proper=Environmentally

47. FoxWeb Message
    or Berger's disease is a clinical/pathological entity..the disease is found Lesbergers du Seignanx Les Echassiers Les bergers du S; IgA Nephropathy IgA  
    http://www.healthlinkusa.com/hl/hlsearchsh.fwx?words=ALL&searchtext=IgA Nephropa

48. Publications
    83359362. Verhagen, A., M. bergers, PE van-Erp, JM Gommans, PC van-de-Kerkhof,and PD Mier. 1984. Epidermal calmodulin and skin disease. Int.J.Dermatol.  
    http://dermatology.azn.nl/fcm/publicat.html

49. CCHS Clinical Digital Library
    Pathology Resources Cotran Robbins Pathologic Basis of disease 6th Ed Access document;AntiGBM Nephritis Access document; bergers Glomerulonephritis Access  
    http://cchs-dl.slis.ua.edu/clinical/nephrology/glomerulonephritis/nephritic.htm
    
    Extractions: Clinical Resources by Topic: Nephrology Acute Glomerulonephritis Clinical Resources Emergency Pediatrics Geriatrics Atlases ... Miscellaneous Resources See also: Distribution of Edema Access document Additional Factors in Diagnosis Access document Approach to the Patient Access document Chapter 273: Pathogenesis of Glomerular Injury Table of contents Introduction: Access document Clinicopathologic Correlates in Glomerular Disease: Access document Nomenclature: Access document Major Clinicopathologic Entities: Access document Major Determinants of Glomerular Injury: Access document Introduction: Access document Primary Insult: Access document Site of Injury: Access document Speed of Onset, Intensity, and Extent of Injury:

50. 131.104.232.9/animalnet/1998/11-1998/an-11-04-98-01.txt
    colleagues at the Center for Molecular Medicine and Infectious disease, VirginiaMaryland crew,the story says that four agents raided the bergers' 75,000-acre  
    http://131.104.232.9/animalnet/1998/11-1998/an-11-04-98-01.txt

51. Urologic And Male Genital Diseases
    The Swedish medical university, Karolinska Institutet. A veritable goldmine of information about Category Health Men s Health Impotence Resources About bergers Glomerulonephritis Univ of Connecticut/Pathol. The Iga Nephropathy(Berger's disease) Home Page R George - (US); IgA Nephropathy (Berger's  
    http://www.mic.ki.se/Diseases/c12.html

52. Ref_artbiogen
    7 Kalkers NF, bergers L, de Groot V, Lazeron RH, van Walderveen MA, Uitdehaag validityof the MS Functional Composite using MRI as a biological disease marker  
    http://www.wissdok.com/ms/ref_artbiogen.html
    
    Extractions: Zu diesem Artikel: html-Version originale Druckversion (pdf-Datei) Technische Vorbemerkung: Es ist Prinzip von W+D, keine externen Links zu verwenden. Wenn im folgenden Links zu Biogen, FDA etc. genannt werden, sind diese nicht etabliert. Gleichwohl gibt es interne Links zu diversen originalen Dokumenten. Die Zahl "300 000" nennt die "American Academy of Neurology" ("AAN") in einem Informationstext; Zitat: Originaltext: "What is Multiple Sclerosis? Multiple sclerosis (MS) is a common disabling neurologic disorder of young adults, affecting at least 300,000 Americans. The average age of diagnosis 30, but it typically starts anywhere between the ages of 15 and 50. Occasionally, the disease begins in children or in older adults. Women are affected at least twice as often as men. It is more common in persons of Northern European heritage, and people with MS are distributed in a remarkable geographic pattern. The highest density occurs in those living furthest from the equator, that is, in temperate zones. There are several types of MS. Most people with MS begin with relapsing remitting disease - that is, it starts with an abrupt onset of neurological problems like numbness or tingling, weakness, or unsteady gait, that either improve spontaneously or with treatment of the symptoms - only to come back again or "relapse." Until recently, when the first treatment became available, most people with relapsing or remitting MS eventually developed a secondary or chronic progressive form of the disease. Ultimately, over one half of people with MS will experience a progressive course."

53. IgA Nephropathy (Berger’s Disease)
    If you would like to make an appointment with a University of Maryland physician,please call 1800-492-5538. IgA nephropathy (bergers' disease)  
    http://www.umm.edu/ency/article/000466prv.htm
    
    Extractions: Privacy Statement Diversity Statement The information on this web site is provided as a public service by the university of Maryland Medical System, a regional health care delivery system that includes an academic medical center (the University of Maryland Medical Center in downtown Baltimore) as well as five community and specialty hospitals and outpatient sites throughout Baltimore and central Maryland. This information is not intended to be a substitute for individual medical advice in diagnosing or treating a health problem. Please consult with your health care provider about your health care concerns. If you would like to make an appointment with a University of Maryland physician, please call 1-800-492-5538

54. Urologicke Choroby A Muzske Genitalne
    Glomerulonefritída bergers Glomerulonephritis PathWeb, U of Connecticut (US)- Brief Notes; Pathophysiology of Glomerular disease - (US); Glomerulonephritis  
    http://www.medik.sk/lekari/chorob13.htm
    
    Extractions: Infekcie moèového traktu Problémy moèenia Let's Talk About Bladder Control For Women - NIDDK/NIH (US) Urinary Incontinence - KKH (SG) Urinary Incontinence (geriatrics) - Mayo Foundation (US) Incontinence in the Elderly C McHenry Martin InContiNet including the AHCPR Guidelines about Urinary Incontinence in Adults and some Critical Reviews of the Literature Non-surgical Treatment of Female Urinary Incontinence H. Sandvik

55. National Multiple Sclerosis Society - Clinical Study Measures
    Kalkers NF, bergers L, de Groot V, Lazeron RH, van Walderveen MA,. F. Concurrent validityof the MS Functional Composite using MRI as a biological disease marker  
    http://www.nationalmssociety.org/\MUCS_references.asp
    
    Extractions: Measures for Use in Clinical Studies of MS Reference List Archibald CJ, McGrath PJ, Ritvo PG, Fisk JD, Bhan V, Maxner CE, Murray TJ. Pain prevalence, severity and impact in a clinic sample of multiple sclerosispatients. Pain. 1994 Jul;58(1):89-93.PMID: 7970843 [PubMed - indexed for MEDLINE] Balcer LJ. Clinical outcome measures for research in multiple sclerosis.J Neuroophthalmol. 2001 Dec;21(4):296-301. Review. PMID: 11756863 [PubMed - indexed for MEDLINE] Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Jak AJ, Kniker JE, Kooijmans MF, Lull JM, Sandrock AW, Simon JH, Simonian NA, Whitaker JN. Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. Arch Neurol. 2001 Jun;58(6):961-7. PMID: 11405811 [PubMed - indexed for MEDLINE] Cohen JA, Fischer JS, Bolibrush DM, Jak AJ, Kniker JE, Mertz LA, Skaramagas TT, Cutter GR. Intrarater and interrater reliability of the MS functional composite outcome measure. Neurology. 2000 Feb 22;54(4):802-6. PMID: 10690966 [PubMed - indexed for MEDLINE] Coulthard-Morris L. Clinical and rehabilitation outcome measures. In Burks

56. Glomerulonephritis Hub
    eSynopsis of bergers glomerulonephritis of the Kidney by Harold Yamase MD. Pathophysiologyof Glomerular disease - by Gerri Schulman, MD., Temple University.  
    http://www.healthubs.com/glomerulonephritis/
    
    Extractions: Glomerulonephritis is a kidney disease. The kidneys' filters become inflamed and scarred and slowly lose their ability to remove wastes and excess water from the blood to make urine. Kidney disease of diabetes, IgA nephropathy, and lupus nephritis are some types of glomerulonephritis. On this hub page, you will find reviewed and categorized links about glomerulonephritis. Overviews Glomerulonephritis - by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Glomerulonephritis from National Kidney Foundation Glomerulonephritis by the University of Maryland Medicine Glomerulonephritis from The Kidney Foundation of Canada Glomerulonephritis from Children's Hospital Boston ... Acute Glomerulonephritis (AGN) - by Nephrologychannel. Glomerulonephritis from Medical College of Wisconsin Membranoproliferative Glomerulonephritis (MPGN) - from The National Kidney Federation, UK. Glomerulonephritis from Taber's Cyclopedic Medical Dictionary Glomerulonephritis - by Jennifer Freeman, DVM.

57. 2002 GRC On Thrombolysis, Fibrinolysis And Extracellular
    20 am 1155 pm, Martin Citron (Amgen Inc.) b-Secretase and Alzheimer's disease . 935am - 1010 am, Gabriele bergers (University of California, San Francisco  
    http://www.grc.uri.edu/programs/2002/thromb.htm

58. Espace Généralistes - Classification Des Glomérulonéphrites
    Translate this page J Am Soc Nephrol 8 199-207. 19. Levy M., et al. 1985. bergers's disease in children.Medicine 64 157-180. 20. Droz D., Kramar A., Nawar T., Noël LH 1984.  
    http://www.amylose.net/esp_gen/glomerulo.htm
    
    Extractions: Espace Généralistes - Glomérulonéphrites Retour à l'Accueil Vous avez la possibilité de rechercher un ou plusieurs mots dans la totalité du site amylose.net grâce à notre MOteur de REcherche. MORE - (c) 2001 Olivier BRUNEL M O R E Vous pouvez rechercher dans l'ensemble de notre site Pour chercher la présence d'un ou de plusieurs mots, écrivez-les en les séparant avec un espace. Par exemple : lundi mardi mercredi Pour chercher la présence de chacun des mots, utilisez le mot AND écrit en majuscules. Par exemple : lundi AND mardi AND mercredi l'amylose 3. Korbet S.M., Schwartz M.M., Lewis E.J. 1988. Minimal change glomerulopathy of adulthood. Am J Nephrol 8 : 291-297. 5. Fuchshuber A., Jean G., Griouval O., Gubler M.C., Broyer M. 1995. Mapping a gene (SNR 1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet 11 : 2155-2158. 6. D'Agati V. 1994. The many masks of focal segmental glomerulosclerosis. Kidney Int 46 : 1223-1241.

59. AMEDEO: The Medical Literature Guide
    in Devic's disease revealed no pathogenic mutations, but polymorphisms also foundin association with multiple sclerosis. Ann Neurol 2002; 51 6612. bergers E  
    http://www.amedeo.com/medicine/ms/ANNNEURO.HTM

60. VUMC - Radiologie
    Bot JCJ, Kamphorst W, Barkhof F, bergers E, Lycklama a Nijeholt GJ, Nicolay K medialtemporal lobe correlates with the diagnosis of early Alzheimer’s disease.  
    http://www.azvu.nl/radiologie/onderzoek/abstracts.html
    
    Extractions: Abstracts Molyneux PD, Miller DH, Filippi M, Yousry T, Radu EW, Ader HJ, Barkhof F . The impact of consensus guidelines on the reproducibility of visual analysis of serial T2 weighted MRI in multiple sclerosis. ENS Journal of Neurology. Vol. 246 suppl 1 pp. 1/56. Sormani MP, Bruzzi P, Miller DH, Gasperini C, Barkhof F , Filippi M. Negative binomial model describing the distribution of enhancing MRI lesions in MS. ISMRM. Philadelphia, Mei 1999. Proceedings pp. 938. Rovaris M, Barkhof F , Bastianello S, Gasperini C, Tubridy N, Yousry TA, Filippi M. Reporting active lesions on serial brain MRI scans in multiple sclerosis: interobserver agreement using CSE, FSE, fast-FLAIR and post-GD T1-weighted images. ISMRM. Philadelphia, Mei 1999. Proceedings pp. 936. Machielsen WCM, Rombouts SARB, Barkhof F , Scheltens Ph, Witter MP. fMRI of visual encoding: reproducibility of activation. ISMRM . Philadelphia, Mei 1999. Proceedings pp. 757. Sie LTL

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

41-60 of 89    Back | 1  | 2  | 3  | 4  | 5  | Next 20